During the study period, 0.80 percent of the non-vaccinated people received a positive test result In the study, which has not yet been published in a specialist magazine, in which scientists from Cambridge University were involved, several thousand symptom-free employees in the British health system were tested for the virus between January 18 and 31. The investigation focused specifically on the protective effect of just one dose. The Biontech / Pfizer vaccine is actually intended to have two doses a few weeks apart.
During the study period, 0.80 percent of the non-vaccinated people received a positive test result (26 of 3252). Among vaccinated individuals whose first dose was at least 12 days earlier, the figure was 0.20 percent (4 in 1989).
“This is great news, the Pfizer– The vaccine not only protects against Sars-CoV-2 disease, it also helps prevent infection and reduces the potential for the virus to be passed on to others, “said Mike Weekes, a specialist with the Cambridge University Hospitals NHS Foundation Trust (CUH), according to a release.
Top jobs of the day
Find the best jobs now and
be notified by email.